McGill Group for Suicide Studies, Douglas Hospital Research Center, Montreal, QC H4H 1R3, Canada.
McGill Group for Suicide Studies, Douglas Hospital Research Center, Montreal, QC H4H 1R3, Canada; Department of Psychiatry, McGill University, Montreal, QC H3A 1A1, Canada.
Methods. 2022 Nov;207:3-10. doi: 10.1016/j.ymeth.2022.08.013. Epub 2022 Sep 3.
The transcriptome of a cell constitutes an essential piece of cellular identity and contributes to the multifaceted complexity and heterogeneity of cell-types within the mammalian brain. Thus, while a wealth of studies have investigated transcriptomic alterations underlying the pathophysiology of diseases of the brain, their use of bulk-tissue homogenates makes it difficult to tease apart whether observed differences are explained by disease state or cellular composition. Cell-type-specific enrichment strategies are, therefore, crucial in the context of gene expression profiling. Laser capture microdissection (LCM) is one such strategy that allows for the capture of specific cell-types, or regions of interest, under microscopic visualization. In this review, we focus on using LCM for cell-type specific gene expression profiling in post-mortem human brain samples. We begin with a discussion of various LCM systems, followed by a walk-through of each step in the LCM to gene expression profiling workflow and a description of some of the limitations associated with LCM. Throughout the review, we highlight important considerations when using LCM with post-mortem human brain samples. Whenever applicable, commercially available kits that have proven successful in the context of LCM with post-mortem human brain samples are described.
细胞的转录组构成了细胞身份的重要组成部分,并为哺乳动物大脑中细胞类型的多方面复杂性和异质性做出贡献。因此,尽管大量研究已经调查了脑疾病病理生理学背后的转录组改变,但它们使用组织匀浆很难区分观察到的差异是由疾病状态还是细胞组成解释的。因此,在基因表达谱分析的背景下,细胞类型特异性富集策略至关重要。激光捕获显微切割(LCM)就是这样一种策略,它允许在显微镜下可视化的情况下捕获特定的细胞类型或感兴趣的区域。在这篇综述中,我们专注于使用 LCM 对死后人类脑组织样本进行细胞类型特异性基因表达谱分析。我们首先讨论了各种 LCM 系统,然后逐步介绍 LCM 到基因表达谱分析工作流程的每一步,并描述了与 LCM 相关的一些限制。在整个综述中,我们强调了在使用死后人类脑组织样本进行 LCM 时需要注意的重要事项。只要适用,我们就会描述在死后人类脑组织样本的 LCM 背景下已被证明成功的商业上可获得的试剂盒。